The effects of a 12-week exercise intervention on respiratory exchange ratio, body composition, thyroid function and lipid metabolism in hypothyroid, obese women
ISRCTN | ISRCTN52563354 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN52563354 |
Secondary identifying numbers | M0010111344 |
- Submission date
- 12/09/2003
- Registration date
- 12/09/2003
- Last edited
- 08/08/2016
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Andrew C Hutchesson
Scientific
Scientific
Consultant in Clinical Chemistry
Royal Bolton Hospital
Minerva Road
Farnworth
Bolton
BL4 0JR
United Kingdom
Phone | +44 (0)1204 390 422 |
---|---|
Andrew.Hutchesson@boltonh-tr.nwest.nhs.uk |
Study information
Study design | Randomised controlled trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | Not specified |
Study type | Not Specified |
Scientific title | The effects of a 12-week exercise intervention on respiratory exchange ratio, body composition, thyroid function and lipid metabolism in hypothyroid, obese women |
Study objectives | Not provided at time of registration |
Ethics approval(s) | Not provided at time of registration |
Health condition(s) or problem(s) studied | Nutritional, Metabolic, Endocrine: Obesity |
Intervention | Patients who appear eligible to the inclusion criteria will be selected from among those having their thyroid function checked, and will be sent a letter via their GP. This letter invites the patient to give consent for the investigator to gain access to her address. If consent is given, the investigator will contact the patient by letter, inviting her to a meeting to discuss the study. Enclosed with this letter will be a patient information sheet and an informed consent form, which the patient will be invited to complete at or within 24 h after the end of the meeting. After recruitment patients randomised to the intervention group will receive a 12-week structured exercise program, supervised by the investigator. Patients in the control group will receive information on 'underactive thyroid' and will have their opportunity to participate in exercise delayed for 12 weeks. Before and after this period, all subjects will undergo: echocardiography and near infra-red spectrometry, respiratory exchange ratio (RER) rest and exercise, body composition analysis and serum lipid profile and thyroid function measurement. After the second (post-intervention) measurements, all subjects will receive a 3-month membership to the Bolton Excel Cardiogym, where they will have the opportunity to complete an exercise program under qualified gym supervision. |
Intervention type | Other |
Primary outcome measure | Percentage reduction in body fat. |
Secondary outcome measures | Not provided at time of registration |
Overall study start date | 11/03/2002 |
Completion date | 01/09/2003 |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Sex | Female |
Target number of participants | Not provided at time of registration |
Key inclusion criteria | 1. Obese (Body Mass Index [BMI] =30.1-40, American College of Sports Medicine [ACSM]) 2. Female 3. Sedentary (>90min of moderate physical activity per week) 4. Age 40-50 5. Subclinical hypothyroidism ('mild hypothyroidism'): elevated thyroid stimulating hormone (TSH) 4-10 mU/l but within-normal-range serum and T4 levels (>8 pmol/l) 6. Able to attend exercise sessions |
Key exclusion criteria | Not provided at time of registration |
Date of first enrolment | 11/03/2002 |
Date of final enrolment | 01/09/2003 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
Consultant in Clinical Chemistry
Bolton
BL4 0JR
United Kingdom
BL4 0JR
United Kingdom
Sponsor information
Department of Health (UK)
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Website | http://www.doh.gov.uk |
---|
Funders
Funder type
Government
Bolton Hospitals NHS Trust (UK)
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Editorial Notes
08/08/21016: No publications found in PubMed, verifying study status with principal investigator.